'Phenoconversion' in adult patients with β-thalassemia
- PMID: 38165006
- DOI: 10.1002/ajh.27194
'Phenoconversion' in adult patients with β-thalassemia
Abstract
Rate and risk factors for phenoconversion from non-transfusion-dependent β-thalassemia (NTDT) to transfusion-dependent β-thalassemia (TDT) during a 10-year follow up of adult patients in Italy.
© 2024 Wiley Periodicals LLC.
References
REFERENCES
-
- Kattamis A, Kwiatkowski JL, Aydinok Y. Thalassaemia. Lancet. 2022;399:2310-2324.
-
- Musallam KM, Cappellini MD, Viprakasit V, Kattamis A, Rivella S, Taher AT. Revisiting the non-transfusion-dependent (NTDT) vs. transfusion-dependent (TDT) thalassemia classification 10 years later. Am J Hematol. 2021;96:E54-E56.
-
- Cappellini MD, Farmakis D, Porter J, Taher A. Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT). 4th ed. Thalassaemia International Federation; 2021.
-
- Taher A, Musallam K, Cappellini MD. Guidelines for the Management of Non-Transfusion-Dependent β-Thalassaemia. 3rd ed. Thalassaemia International Federation; 2023.
-
- Musallam KM, Bou-Fakhredin R, Cappellini MD, Taher AT. 2021 update on clinical trials in beta-thalassemia. Am J Hematol. 2021;96:1518-1531.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources